VERONA PHARMA
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough. The company creates therapies to address unmet medical requirements in the treatment of respiratory disorders. Verona Pharma was established in 2005 by Clive Page in London, England.
VERONA PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.veronapharma.com
Total Employee:
51+
Status:
Active
Contact:
+44 20 7863 3300
Email Addresses:
[email protected]
Total Funding:
1.51 B USD
Technology used in webpage:
Domain Not Resolving IPv6 ReCAPTCHA ReCAPTCHA V2 UNPKG Akamai Hosted
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Oaktree Capital Management
Oaktree Capital Management investment in Post-IPO Debt - Verona Pharma
Ontario Municipal Employees Retirement System
Ontario Municipal Employees Retirement System investment in Post-IPO Debt - Verona Pharma
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Verona Pharma
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Verona Pharma
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Verona Pharma
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Verona Pharma
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Verona Pharma
Abingworth
Abingworth investment in Post-IPO Equity - Verona Pharma
David Ebsworth
David Ebsworth investment in Post-IPO Equity - Verona Pharma
Foresite Capital
Foresite Capital investment in Post-IPO Equity - Verona Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-03 | Verona Pharma appoint new CEO and CFO |
| 2020-01-07 | Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations |
Official Site Inspections
http://www.veronapharma.com Semrush global rank: 1.46 M Semrush visits lastest month: 17.06 K
- Host name: 192.0.66.210
- IP address: 192.0.66.210
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Verona Pharma"
Verona Pharma | Innovative Respiratory Treatments
Nov 19, 2024 · We’re a biopharmaceutical company focused on developing and commercializing innovative prescription medicines. To learn more about Verona Pharma, please get in touch. © …See details»
About Us | Verona Pharma
Verona Pharma is committed to improving the lives of patients with respiratory conditions through innovative prescription medicines. Learn about our vision to meet unmet medical needs, our agile approach, and leadership team.See details»
Contact Us - Verona Pharma
We welcome inquires about Verona Pharma, our innovative research and partnering opportunities. Please detail your inquiry for a more accurate and personalized reply. This …See details»
Verona Pharma - Crunchbase Company Profile
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough. The …See details»
Verona Pharma - Org Chart, Teams, Culture & Jobs - The Org
Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of respiratory diseases with …See details»
Verona Pharma - LinkedIn
Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet...See details»
Verona Pharma plc - AnnualReports.com
Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.See details»
Verona Pharma Inc. | North Carolina Biotech Center
Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic …See details»
Developing innovative therapies for the treatment of respiratory …
This presentation contains “forward‐looking” statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc …See details»
Company Leadership - Verona Pharma
Meet Verona Pharma's leadership team and Board of Directors, with extensive experience in global life sciences and a proven track record in the development and commercialization of …See details»
Verona Pharma Company Overview, Contact Details
May 9, 2024 · Verona Pharma uses 8 technology products and services including Power BI, SAS, DigitalOcean Spaces, and more. Explore Verona Pharma 's tech stack below. Verona Pharma …See details»
Verona Pharma - Craft
Verona Pharma plc is a United Kingdom-based bio-pharmaceutical company. The Company is engaged in developing drugs for the treatment of chronic respiratory diseases, such as chronic …See details»
Verona Pharma - Overview, News & Similar companies - ZoomInfo
Oct 13, 2024 · Verona Pharma contact info: Phone number: +44 2032834200 Website: www.veronapharma.com What does Verona Pharma do? Verona Pharma is a clinical-stage …See details»
Verona Pharma Announces US FDA Approval of Ohtuvayre™ …
Jun 26, 2024 · LONDON and RALEIGH, N.C., June 26, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food …See details»
Verona Pharma Reports Third Quarter 2024 Financial
Nov 4, 2024 · LONDON and RALEIGH, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical …See details»
Verona Pharma Receives $650M Investment from Oaktree Capital …
May 9, 2024 · Verona Pharma announced that it has secured strategic financing of up to $650 million from Oaktree Capital Management and OMERS Life Sciences, aiming to prepare for …See details»
Verona Pharma Announces $650 Million Strategic Financing with …
May 9, 2024 · Non-dilutive funding will support planned US commercial launch and expansion of ensifentrine’s clinical activities Cash runway extended beyond 2026 LONDON and RALEIGH, …See details»
Investor Relations | Verona Pharma
Nov 19, 2024 · Learn about Verona Pharma's innovative respiratory treatments and latest financial updates. Explore our investor presentation, recent results, and news for insights into …See details»
Verona Pharma, which has US HQ in Raleigh, lands $219M …
Jun 15, 2021 · Verona Pharma has clinched a $219 million deal to market its “first-in-class” drug, ensifentrine, targeting chronic obstructive pulmonary disease (COPD), in China.See details»
Verona Pharma Reports Third Quarter 2024 Financial Results and …
Nov 4, 2024 · LONDON and RALEIGH, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical …See details»